Emergence of Erythromycin-Resistant and Pertactin-and Filamentous Hemagglutinin-Deficient Bordetella pertussis Strains—Beijing,China,2022-2023  

作　　者：Guilan Zhou Ying Li Hairui Wang Yuanyuan Wang Yuan Gao Juan Xu Fengshuang Wang Tao Peng Maojun Zhang Zhujun Shao 

机构地区：[1]National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases,National Institute for Communicable Disease Control and Prevention,Chinese Center for Disease Control and Prevention,Beijing,China [2]Shunyi District Center for Disease Control and Prevention,Beijing,China

出　　处：《China CDC weekly》2024年第20期437-441,共5页中国疾病预防控制中心周报（英文）

基　　金：Supported by the National Key Research and Development Program of China(grant number 2021YFC2301000);the National Natural Science Foundation of China(NSFC)(grant number 81973106).

摘　　要：What is already known about this topic?Pertussis has reemerged as a significant public health threat,primarily due to variations in Bordetella pertussis strains,antimicrobial resistance,and vaccine evasion.What is added by this report?All isolated strains were identified as ptxA1/ptxC2/ptxP3/prn150/fim2-1/fim3-1/fhaB1/tcfA2 type and exhibited resistance to erythromycin.

关 键 词：VACCINE PERTUSSIS primarily 

分 类 号：R51[医药卫生—内科学] R186[医药卫生—临床医学]